Abstract | PURPOSE OF REVIEW: This review will describe the contemporary management of castration-resistant prostate cancer in the context of multiple recent advances. RECENT FINDINGS: SUMMARY:
|
Authors | Guru Sonpavde, Cora N Sternberg |
Journal | Current opinion in urology
(Curr Opin Urol)
Vol. 21
Issue 3
Pg. 241-7
(May 2011)
ISSN: 1473-6586 [Electronic] United States |
PMID | 21455038
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Androstenes
- Androstenols
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- RANK Ligand
- Taxoids
- Tissue Extracts
- Denosumab
- cabazitaxel
- sipuleucel-T
- abiraterone
|
Topics |
- Androstenes
- Androstenols
(therapeutic use)
- Antibodies, Monoclonal
(therapeutic use)
- Antibodies, Monoclonal, Humanized
- Castration
- Denosumab
- Drug Therapy
- Humans
- Male
- Prostatic Neoplasms
(pathology)
- RANK Ligand
(therapeutic use)
- Taxoids
(therapeutic use)
- Testicular Neoplasms
(secondary, therapy)
- Tissue Extracts
(therapeutic use)
|